Kynurenine pathway activation could be a biomarker for CI after acute COVID-19

Time : 23rd of June 2022 12:11:25 PM

Patients with cognitive impairment (CI) after two months of COVID-19 diagnosis had slighter increased levels of kynurenine pathway metabolism compared to those without CI, as per a study. However, there was no association between CI and interferon-gamma, monocyte chemoattractant protein-1, interleukins, peripheral brain biomarkers, and tumour necrosis factor-alpha.

  Twitter @Kevin_McKernan